Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, WOM

Santa Barbara Cottage Hospital Enhances Maternal and Fetal Safety with Go-Live of PeriGen's PeriWatch Vigilance


CARY, N.C., April 7, 2020 /PRNewswire/ -- PeriGen®, an innovator in perinatal early warning systems, today announced that Santa Barbara Cottage Hospital, a 519-bed acute care teaching hospital and trauma center that is part of the not-for-profit Cottage Health system, is now using PeriGen's PeriWatch Vigilance® automated maternal-fetal early warning system (EWS) in its labor and delivery (L&D) department.

Founded in 1888 by 50 women determined to provide a healthcare facility for the growing community of Santa Barbara, the hospital today averages more than 20,000 inpatient admissions, including 2,400 births, along with nearly 73,000 emergency department visits. It is the largest hospital of its kind between Los Angeles and the San Francisco Bay area.

Since it went live in January 2020, PeriWatch Vigilance has been helping Santa Barbara Cottage Hospital enhance the care and safety of mothers and babies during L&D. Its HUB offers a consolidated view of all patients during the birthing process that helps improve acuity awareness. The HUB enables PeriWatch Vigilance to deliver monitoring and notification of developing issues that is visible at both bedside workstations and the nurses' station.

"As a director in OB, PeriWatch Vigilance helps me keep a finger on the pulse of the unit by providing a complete overview with just one click of the mouse," said Libby Smith, Director of Women's Services at Santa Barbara Cottage Hospital. "When I walk through the unit, the notifications are being displayed on the Vigilance HUB in a consolidated, easily viewed screen that help me prioritize where to focus my initial attention. The installation of Vigilance went so well the staff was able to continue working during the go live with minimal to no interruptions. The staff felt it was an excellent implementation and expressed they had never experienced such a smooth roll out."

Smith feels particularly fortunate that PeriWatch Vigilance went live and the staff had time to become familiar with it before the current COVID-19 crisis hit.

"Although there is a very real risk of nurses flexing in multiple assignments and L&D patients being isolated as a result of COVID-19, I am confident that PeriWatch Vigilance will continue to help us respond quickly and confidently to patients in distress," she said.

PeriWatch Vigilance is an automated early warning system for obstetrics designed to enhance clinical efficiency, timely intervention and standardization of care. It leverages artificial intelligence techniques to analyze electronic fetal monitoring (EFM) tracings continuously to show trends over time. It works seamlessly with an organization's current EFM and electronic medical records (EMR) systems, including Obix and Epic, and does not require replacing any systems in place. Santa Barbara Cottage Hospital is using the full PeriWatch Vigilance suite of tools, including:

"Santa Barbara Cottage Hospital is simply never complacent when it comes to patient care, and that has resulted in a well-earned reputation for being one of the top hospitals in the country," said PeriGen CEO Matthew Sappern. "To the Cottage team, PeriWatch Vigilance is the logical next step, and a big step, beyond the limited benefits of legacy technology into the future of using data in a continuous, quantifiable and ultimately more effective way for patient care. Libby and her team are great partners as we consider how to extend our capabilities."

ABOUT SANTA BARBARA COTTAGE HOSPITAL
Founded in 1888 by 50 women determined to provide a healthcare facility for the growing community of Santa Barbara, Santa Barbara Cottage Hospital today is part of the not-for-profit Cottage Health system. The 519-bed acute care teaching hospital and trauma center is the largest of its kind between Los Angeles and the San Francisco Bay area. It averages more than 20,000 inpatient admissions, nearly 73,000 emergency department visits, and 2,400 births, and is renowned for its breadth of services. For more information, please visit https://www.cottagehealth.org.

ABOUT PERIGEN, INC.
PeriGen offers innovative perinatal software solutions that incorporate advanced statistical analysis features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch® platform to provide consistent analysis and efficient display of complex data to promote better human recognition and communication about impending problems during labor. With PeriWatch®, clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; visit us on TwitterLinkedInYouTube, and Facebook; or call 984.208.4250 or email.

Media Contact for PeriGen:                                                                                       
Stacy State
Amendola Communications for PeriGen
502.744.7409
[email protected]

 

SOURCE PeriGen


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: